Tirtha Chakraborty
Chief Tech/Sci/R&D Officer at VOR BIOPHARMA INC.
Net worth: 304 696 $ as of 2024-04-29
Tirtha Chakraborty active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VOR BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 2020-10-31 | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Consultant / Advisor | 2023-07-23 | - |
Career history of Tirtha Chakraborty
Former positions of Tirtha Chakraborty
| Companies | Position | Start | End |
|---|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 2018-09-30 | 2019-09-30 |
| CRISPR THERAPEUTICS AG | Director/Board Member | 2014-12-31 | 2018-09-30 |
| Corporate Officer/Principal | 2014-12-31 | 2018-09-30 |
Training of Tirtha Chakraborty
| Tata Institute of Fundamental Research | Doctorate Degree |
Statistics
International
| United States | 3 |
| Switzerland | 2 |
| India | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| VOR BIOPHARMA INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
| Private companies | 1 |
|---|---|
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Commercial Services |
- Stock Market
- Insiders
- Tirtha Chakraborty
- Experience